MWMichael J. Walsh

Michael J. Walsh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Walsh has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging

    by Zachary Caterer, Jordan Langlois, Connor McKeown, Mikayla Hady, Samuel Stumo, Suman Setty, Michael Walsh, Rahul Gomes

    Kidney and renal pelvic cancer are a significant cause of cancer-related deaths, with the most common malignant kidney tumor being renal cell carcinoma (RCC). Chromophobe renal cell carcinoma is a rarer form of RCC that poses significant challenges to accurate diagnosis, as it shares many histologic features with Oncocytoma, a benign renal tumor. Biopsies for histopathological and immunohistochemical analysis have limitations in distinguishing chromophobe RCC from Oncocytoma. Syndromic cases may also have tumors with overlapping features. Techniques such as infrared (IR) spectroscopic imaging have shown promise as an alternative approach to tissue diagnostics. In this study, we propose a deep-learning-based framework for automating classification in kidney tumor tissue microarrays (TMAs) using an IR dataset. Feature selection algorithms reduce data dimensionality, followed by a deep learning classification approach. A classification accuracy of 91.3% was observed for validation data, even with the use of 13.6% of all wavelengths, thereby reducing training time by 21% compared to using the entire spectrum. Through the integration of scalable deep learning models coupled with feature selection, we have developed a classification pipeline with high predictive power, which could be integrated into a high-throughput real-time IR imaging system. This would create an advanced diagnostic tool for the detection and classification of renal tumors, namely chromophobe RCC and Oncocytoma. This may impact patient outcomes and treatment strategies.


  • Open Access

    Infrared spectral microscopy as a tool to monitor lung fibrosis development in a model system

    by Vidyani Suryadevara, Shaiju S. Nazeer, Hari Sreedhar, Oluwatobi Adelaja, André Kajdacsy-Balla, Viswanathan Natarajan, Michael J. Walsh

    Tissue fibrosis is a progressive and destructive disease process that can occur in many different organs including the liver, kidney, skin, and lungs. Fibrosis is typically initiated by inflammation as a result of chronic insults such as infection, chemicals and autoimmune diseases. Current approaches to examine organ fibrosis are limited to radiological and histological analyses. Infrared spectroscopic imaging offers a potential alternative approach to gain insight into biochemical changes associated with fibrosis progression. In this study, we demonstrate that IR imaging of a mouse model of pulmonary fibrosis can identify biochemical changes observed with fibrosis progression and the beginning of resolution using K-means analysis, spectral ratios and multivariate data analysis. This study demonstrates that IR imaging may be a useful approach to understand the biochemical events associated with fibrosis initiation, progression and resolution for both the clinical setting and for assessing novel anti-fibrotic drugs in a model system. (C) 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement


  • Label-free Identification of Antibody-mediated Rejection in Cardiac Allograft Biopsies Using Infrared Spectroscopic Imaging

    by Imran Uraizee, Vishal K. Varma, Hari Bs Sreedhar, Francesca Bs Gambacorta, Shaiju S. Nazeer, Aliya Husain, Michael J. Walsh

    Background.: Antibody-mediated rejection (AMR) in cardiac allograft recipients remains less well-understood than acute cellular rejection, is associated with worse outcomes, and portends a greater risk of developing chronic allograft vasculopathy. Diffuse immunohistochemical C4d staining of capillary endothelia in formalin-fixed, paraffin-embedded right ventricular endomyocardial biopsies is diagnostic of immunopathologic AMR but serves more as a late-stage marker. Infrared (IR) spectroscopy may be a useful tool in earlier detection of rejection. We performed mid-IR spectroscopy to identify a unique biochemical signature for AMR. Methods.: A total of 30 posttransplant formalin-fixed paraffin-embedded right ventricular tissue biopsies (14 positive for C4d and 16 negative for C4d) and 14 native heart biopsies were sectioned for IR analysis. Infrared images of entire sections were acquired and regions of interest from cardiomyocytes were identified. Extracted spectra were averaged across many pixels within each region of interest. Principal component analysis coupled with linear discriminant analysis and predictive classifiers were applied to the data. Results.: Comparison of averaged mid-IR spectra revealed unique features among C4d-positive, C4d-negative, and native heart biopsies. Principal component analysis coupled with linear discriminant analysis and classification models demonstrated that spectral features from the mid-IR fingerprint region of these 3 groups permitted accurate automated classification into each group. Conclusions.: In cardiac allograft biopsies with immunopathologic AMR, IR spectroscopy reveals a biochemical signature unique to AMR compared with that of nonrejecting cardiac allografts and native hearts. Future study will focus on the predictive capabilities of this IR signature.


  • Detection of amyloidosis in human tissues using mid-infrared spectroscopic imaging

    by David Martinez Marin, Hari Sreedhar, Michael J. Walsh, Maria M. Picken

    (2019). Detection of amyloidosis in human tissues using mid-infrared spectroscopic imaging. Amyloid: Vol. 26, Proceedings of the XVI International Symposium on Amyloidosis Kumamoto, Japan 26-29 March 2018, pp. 93-94.

  • Deep learning for FTIR histology: leveraging spatial and spectral features with convolutional neural networks

    by Sebastian Berisha, Mahsa Lotfollahi, Jahandar Jahanipour, Ilker Gurcan, Michael Walsh, Rohit Bhargava, Hien Van Nguyen, David Mayerich

    Current methods for cancer detection rely on tissue biopsy, chemical labeling/staining, and examination of the tissue by a pathologist. Though these methods continue to remain the gold standard, they are non-quantitative and susceptible to human error. Fourier transform infrared (FTIR) spectroscopic imaging has shown potential as a quantitative alternative to traditional histology. However, identification of histological components requires reliable classification based on molecular spectra, which are susceptible to artifacts introduced by noise and scattering. Several tissue types, particularly in heterogeneous tissue regions, tend to confound traditional classification methods. Convolutional neural networks (CNNs) are the current state-of-the-art in image classification, providing the ability to learn spatial characteristics of images. In this paper, we demonstrate that CNNs with architectures designed to process both spectral and spatial information can significantly improve classifier performance over per-pixel spectral classification. We report classification results after applying CNNs to data from tissue microarrays (TMAs) to identify six major cellular and acellular constituents of tissue, namely adipocytes, blood, collagen, epithelium, necrosis, and myofibroblasts. Experimental results show that the use of spatial information in addition to the spectral information brings significant improvements in the classifier performance and allows classification of cellular subtypes, such as adipocytes, that exhibit minimal chemical information but have distinct spatial characteristics. This work demonstrates the application and efficiency of deep learning algorithms in improving the diagnostic techniques in clinical and research activities related to cancer.


  • Selecting optimal features from Fourier transform infrared spectroscopy for discrete-frequency imaging

    by Rupali Mankar, Michael J. Walsh, Rohit Bhargava, Saurabh Prasad, David Mayerich

    Tissue histology utilizing chemical and immunohistochemical labels plays an important role in biomedicine and disease diagnosis. Recent research suggests that mid-infrared (IR) spectroscopic imaging may augment histology by providing quantitative molecular information. One of the major barriers to this approach is long acquisition time using Fourier-transform infrared (FTIR) spectroscopy. Recent advances in discrete frequency sources, particularly quantum cascade lasers (QCLs), may mitigate this problem by allowing selective sampling of the absorption spectrum. However, DFIR imaging only provides a significant advantage when the number of spectral samples is minimized, requiring a priori knowledge of important spectral features. In this paper, we demonstrate the use of a GPU-based genetic algorithm (GA) using linear discriminant analysis (LDA) for DFIR feature selection. Our proposed method relies on pre-acquired broadband FTIR images for feature selection. Based on user-selected criteria for classification accuracy, our algorithm provides a minimal set of features that can be used with DFIR in a time-frame more practical for clinical diagnosis.


  • Open Access

    Predicting Fibrosis Progression in Renal Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging

    by Vishal K. Varma, Andre Kajdacsy-Balla, Sanjeev Akkina, Suman Setty, Michael J. Walsh

    Renal transplants have not seen a significant improvement in their 10-year graft life. Chronic damage accumulation often leads to interstitial fibrosis and tubular atrophy (IF/TA) and thus graft function loss over time. For this reason, IF/TA has been the chief suspect for a potential prognostic marker for long term outcomes. In this study, we have used infrared spectroscopic (IR) imaging to interrogate the biochemistry of regions of fibrosis from renal transplant biopsies to identify a biochemical signature that can predict rapid progression of fibrosis. IR imaging represents an approach that permits label-free biochemical imaging of human tissues towards identifying novel biomarkers for disease diagnosis or prognosis. Two cohorts were identified as progressors (n = 5, > 50% fibrosis increase between time points) and non-progressors (n = 5, < 5% increase between time points). Each patient had an early time point and late time point biopsy. Collagen associated carbohydrate moieties (ν(C–O), 1035 cm−1 and ν(C–O–C),1079 cm−1) spectral ratios demonstrated good separation between the two cohorts (p = 0.001). This was true for late and early time point biopsies suggesting the regions of fibrosis are biochemically altered in cases undergoing progressive fibrosis. Thus, IR imaging can potentially predict rapid progression of fibrosis using histologically normal early time point biopsies.


  • Infrared spectroscopic imaging: Label-free biochemical analysis of stroma and tissue fibrosis

    by Shaiju S. Nazeer, Hari Sreedhar, Vishal K. Varma, David Martinez-Marin, Christine Massie, Michael J. Walsh


  • Accounting for tissue heterogeneity in infrared spectroscopic imaging for accurate diagnosis of thyroid carcinoma subtypes

    by David Martinez-Marin, Hari Sreedhar, Vishal K. Varma, Catarina Eloy, Manuel Sobrinho-Simões, André Kajdacsy-Balla, Michael J. Walsh


  • Applications of QCL mid-IR imaging to the advancement of pathology

    by Hari Sreedhar, Vishal K. Varma, Benjamin Bird, Grace Guzman, Michael J. Walsh